DK533189A - 3beta,alfa7beta-hydroxy-substituerede steroider og beslaegtede steroide forbindelser - Google Patents

3beta,alfa7beta-hydroxy-substituerede steroider og beslaegtede steroide forbindelser

Info

Publication number
DK533189A
DK533189A DK533189A DK533189A DK533189A DK 533189 A DK533189 A DK 533189A DK 533189 A DK533189 A DK 533189A DK 533189 A DK533189 A DK 533189A DK 533189 A DK533189 A DK 533189A
Authority
DK
Denmark
Prior art keywords
compounds
hydroxy
alfa7beta
3beta
steroid compounds
Prior art date
Application number
DK533189A
Other languages
English (en)
Other versions
DK533189D0 (da
Inventor
John O'neal Johnston
Gene Warwick Holbert
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK533189D0 publication Critical patent/DK533189D0/da
Publication of DK533189A publication Critical patent/DK533189A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025Esters

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicon Polymers (AREA)
DK533189A 1988-10-27 1989-10-26 3beta,alfa7beta-hydroxy-substituerede steroider og beslaegtede steroide forbindelser DK533189A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/263,091 US4882322A (en) 1988-10-27 1988-10-27 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Publications (2)

Publication Number Publication Date
DK533189D0 DK533189D0 (da) 1989-10-26
DK533189A true DK533189A (da) 1990-04-28

Family

ID=23000340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK533189A DK533189A (da) 1988-10-27 1989-10-26 3beta,alfa7beta-hydroxy-substituerede steroider og beslaegtede steroide forbindelser

Country Status (18)

Country Link
US (1) US4882322A (da)
EP (1) EP0366144B1 (da)
JP (1) JP2750621B2 (da)
KR (1) KR900006360A (da)
CN (1) CN1042363A (da)
AT (1) ATE111478T1 (da)
AU (1) AU619608B2 (da)
CA (1) CA2001264C (da)
DE (1) DE68918219T2 (da)
DK (1) DK533189A (da)
ES (1) ES2063801T3 (da)
FI (1) FI895084A7 (da)
HU (1) HU204065B (da)
IL (1) IL92103A0 (da)
NO (1) NO173097C (da)
NZ (1) NZ231107A (da)
PT (1) PT92113B (da)
ZA (1) ZA898025B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
JP2007512361A (ja) * 2003-11-24 2007-05-17 メルク エンド カムパニー インコーポレーテッド エストロゲン受容体調節剤
AU2004292555A1 (en) * 2003-11-24 2005-06-09 Merck & Co., Inc. Estrogen receptor modulators
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CN103555806B (zh) * 2013-11-16 2015-05-13 江南大学 一种高效利用亚麻刺盘孢霉合成7α-羟基-雄甾烯酮的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives

Also Published As

Publication number Publication date
AU619608B2 (en) 1992-01-30
NO894276D0 (no) 1989-10-26
IL92103A0 (en) 1990-07-12
JP2750621B2 (ja) 1998-05-13
CN1042363A (zh) 1990-05-23
FI895084A0 (fi) 1989-10-26
HU204065B (en) 1991-11-28
JPH02174793A (ja) 1990-07-06
PT92113A (pt) 1990-04-30
EP0366144B1 (en) 1994-09-14
CA2001264C (en) 2001-05-01
PT92113B (pt) 1995-06-30
ATE111478T1 (de) 1994-09-15
DE68918219T2 (de) 1995-02-02
HU895457D0 (en) 1990-01-28
NO894276L (no) 1990-04-30
AU4367989A (en) 1990-05-31
EP0366144A1 (en) 1990-05-02
FI895084A7 (fi) 1990-04-28
US4882322A (en) 1989-11-21
NO173097C (no) 1993-10-27
DK533189D0 (da) 1989-10-26
CA2001264A1 (en) 1990-04-27
HUT52113A (en) 1990-06-28
KR900006360A (ko) 1990-05-08
ES2063801T3 (es) 1995-01-16
DE68918219D1 (de) 1994-10-20
ZA898025B (en) 1990-07-25
NZ231107A (en) 1992-03-26
NO173097B (no) 1993-07-19

Similar Documents

Publication Publication Date Title
DK533189D0 (da) 3beta,alfa7beta-hydroxy-substituerede steroider og beslaegtede steroide forbindelser
ES8802429A1 (es) Un procedimiento para la preparacion de androsta-1,4-dien-3,17-dionas
ATE186913T1 (de) 17-substituierte steroide, verwendbar bei behandlung von krebs
NO20065784L (no) Steroidforbindelser og anvendelse av slike
ATE185812T1 (de) 17-spiromethylensteroide
UA6044A1 (uk) Спосіб одержання метіленових похідних андроста-1,4 -діен-3,17-діона
GR1000597B (el) Παραγοντας αναστολης αναπτυξης και χρηση του.
NO842408L (no) Fremgangsmaate ved fremstilling av 1-alkyl-androsta-1,4-dien-3,17-dioner
AP9801431A0 (en) Steroid bisphosphonates.
DE68911157D1 (de) Synthese von 6-Methylenandrosta-1,4-dien-3,17-dion-Derivate.
MX9303557A (es) Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel.
DK0559706T3 (da) 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer.
DE69219217D1 (de) Neue 16-Methyl substituierte Steroidderivate von Pregna-1,4-dien-3,20-dion, ihre Herstellung, ihre Verwendung zur Herstellung von 16-Methylene-substituierte Steroide und neue Zwischenprodukten dafür
DE60014096D1 (de) Durch 11-beta-aryl-17,17-spirothiolan substituierte steroide
NO864365D0 (no) Fremgangsmaate for fremstilling av 1-methyl-15alfa-alkyl-androsta-1,4-dien-3,17-dioner.
WO1990015067A3 (fr) NOUVEAUX PROCEDES D'OBTENTION DE 6-METHYL 19-NOR STEROIDES ET LEUR CONVERSION EN 19-NOR PREGNADIENES 17α-SUBSTITUES
JPS5777698A (en) 18-substituted pregn-4-ene-3,20-dione
GB970487A (en) Novel steroids compounds and processes for the preparation thereof
DE69111108D1 (de) Haloethyl substituierte enzymhemmende Steroiden.
MXPA03005224A (es) Esteroides de metileno como androgenos novedosos.
BA97185B1 (bs) Postupak za dobijanje supstituisanih androsta-1,4-dien-3,17-diona
RU95113491A (ru) Новые стероиды, способ лечения, фармацевтическая композиция, способы получения

Legal Events

Date Code Title Description
ATS Application withdrawn